SCHEMBL19902354

SCHEMBL19902354

CCC(=O)c1ccn(CC2CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 5/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
KDM4C Q9H3R0 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 7/20 0.36
NPC1 O15118 6/20 0.36
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28112266 0.94 KMT2A (0.40) RIPK1KMT2APOLBTDP1ALDH1A1
SCHEMBL17065278 0.84 KMT2A (0.40) KMT2APOLBTDP1ALDH1A1CYP1A2
SCHEMBL17438083 0.82 SMN1; SMN2 (0.47) KMT2APOLBTDP1ALDH1A1CYP1A2
SCHEMBL2827007 0.81 POLB (0.37) KMT2APOLBTDP1ALDH1A1KDM4C
SCHEMBL24914915 0.81 KMT2A (0.44) KMT2APOLBTDP1ALDH1A1CYP1A2
SCHEMBL31708636 0.80 CNR2 (0.39) RIPK1KMT2APOLBTDP1ALDH1A1
SCHEMBL17452574 0.80 KMT2A (0.38) KMT2APOLBTDP1ALDH1A1CYP1A2
SCHEMBL17437913 0.80 KMT2A (0.59) KMT2APOLBTDP1ALDH1A1CYP1A2
SCHEMBL28111821 0.80 ALDH1A1 (0.54) KMT2APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL17065285 0.78 KMT2A (0.41) RIPK1KMT2APOLBTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902702-B2 Spirocycloheptanes as inhibitors of rock BRISTOL-MYERS SQUIBB COMPANY (US) 2018-02-27 US disclosed
CN-106068265-A Dihydropyridone MGAT2 inhibitors for the treatment of metabolic disorders 百时美施贵宝公司 2016-11-02 CN disclosed